The Hospital of Central Connecticut to participate in national pilot study for disc implant
New Britain [March 08 2011] -
For information on this pilot study, please Cathy Couch, 860-348-9571
The Hospital of Central Connecticut is one of only five sites in the United States selected to participate in a pilot study for the TRIUMPH® Lumbar Disc, for treatment of degenerative disc disease – a leading cause of chronic neck and back pain.
The investigational TRIUMPH® device, developed by Globus Medical, Inc., is the only lumbar artificial disc developed for a posterolateral surgical approach. This approach involves gently separating the muscles of the lower back to reach the disc, rather than operating through the abdominal cavity to access the disc, as is the case with traditional artificial disc surgery.
The purpose of the pilot study is to evaluate the TRIUMPH® disc for the treatment of patients suffering from degenerative disc disease at one vertebral level between L1 and S1. The study is open to men and women between the ages of 18 and 65.
Ahmed Khan, M.D., of Central Connecticut Neurosurgery and Spine, is the principal investigator for the study. Khan and The Hospital of Central Connecticut are currently seeking to enroll patients in the TRIUMPH® IDE Pilot Study. Please contact Cathy Couch, R.N., at 860-348-9571 or email@example.com if you are interested in participating in this clinical trial.
Contact: Nancy Martin, 860-224-5900, ext. 4366
HCC Corporate Communications
(860) 224-5695 •
Fax (860) 224-5779